The acquisition of health data (biomarkers, vital signals, etc.) on the field will revolutionize medicine by improving the management, diagnosis and monitoring of pathologies.

​

However, there are still very few solutions that allow for continuous data acquisition other than vital signals and blood sugar levels. To broaden the spectrum of applications by offering a wider range of biomarkers, Grapheal is developing a new generation of connected medical devices (in-vitro diagnostic tests, skin patches) to facilitate and accelerate decision-making by caregivers in a digital and decentralized healthcare system.